Navigation Links
Will this be the end of hamburger disease?
Date:11/29/2010

This release is available in French.

Montreal, November 25, 2010 Hamburger disease, a debilitating form of food poisoning, may be a thing of the past. New findings from an international research collaboration conducted by the French National Institute for Agronomic Research (INRA), involving the Universit de Montral are the first to show how the contaminating E.coli bacterium is able to survive in the competitive environment of a cow's intestine by scavenging specific food sources. Published in this month's Environmental Microbiology, and featured in Nature Reviews Microbiology, this study may lead to non-medicinal methods for eradicating this invasive bug.

"We studied E.coli O157:H7, which is the most prevalent species of bacteria associated with larger outbreaks," says Jose Harel, co-author of the study and director of the Groupe de Recherche sur les Maladies Infectieuses du Porc at the Universit de Montral's Faculty of Veterinary Medicine. "These outbreaks have been associated with direct contact with the farm environment and with the consumption of meat, raw milk and dairy products. Reduction or eradication of O157:H7 in cows will lead to a substantial decrease in food contamination and consequential human infections."

O157:H7, a wily bacteria

The intestine is a complex environment with a high number and diversity of bacteria. Most of these bugs are not harmful and many contribute to proper bowel function. However, your guts are a battleground for wars between these species as they engage in a struggle to obtain carbon, nitrogen and other energy sources. Those that win the battle for resources survive and multiply while the losers disappear.

Harel and her collaborators' from France's Institut National de la Recherche Agronomique and Lallemand Animal Nutrition, first step was to demonstrate that O157:H7 does in fact thrive in the bovine intestine. Once this was established, they went on to determine why these particular bacteria find the cow intestine such a great place to live. They found that O157:H7 is unusual because it can forage nitrogen from ethanolamine, a chemical present in the cow's intestine. Because other bacteria cannot process ethanolamine, O157:H7 has this source of nutrition to itself. "The ability of O157:H7 to use ethanolamine as a source of nitrogen gives it the nutritional and competitive advantage to survive," says Harel.

It is all in the genes

The final step for Harel and colleagues was to determine how O157:H7 was able to process the ethanolamine so it could be used as a nitrogen source. Genetic analyses revealed that 0157:H7 had specific genes that allowed it to do so.

"We now know that this bacteria has evolved a genetic program that allows it to process ethanolamine and therefore outcompete its neighbours and survive and multiply in the intestine," says Harel. "This new-found knowledge will help us select appropriate feed or probiotics in an attempt to eliminate the food source of this contaminating bug. This in turn, should limit the spread of this bug into the food chain."

About hamburger disease:

Hamburger disease, otherwise known as haemolytic uremic syndrome, can occur after a person has been infected with the E. coli O157:H7. It can result in the destruction of cells that cause clotting of the blood and red blood cells. Kidney failure may result due to the damage of the small blood vessels and tubules in the kidneys. It usually affects children between the ages of 1 and 10 years, but may also occur in adults. HUS affects 2 to 4 people per 100 000 and occurs all over the world.


'/>"/>

Contact: Julie Gazaille
j.cordeau-gazaille@umontreal.ca
514-343-6796
University of Montreal
Source:Eurekalert

Related biology news :

1. Think saturated fat contributes to heart disease? Think again
2. Can an over-the-counter vitamin-like substance slow the progression of Parkinsons disease?
3. How much omega-3 fatty acid do we need to prevent cardiovascular disease?
4. Toward an explanation for Crohns disease?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... WASHINGTON , Dec. 5, 2016  The ... (NIJ), today published "Can CT Scans Enhance or ... examines the potential of supporting or replacing forensic ... a CT scan. In response to ... NIJ is exploring using CT scans as a ...
(Date:11/29/2016)... Nov. 29, 2016 BioDirection, a privately held ... for the objective detection of concussion and other traumatic ... successfully completed a meeting with the U.S. Food and ... test Pre-Submission Package. During the meeting company representatives reviewed ... a precursor to commencement of a planned pilot trial. ...
(Date:11/22/2016)... India , November 22, 2016 According to ... (Fingerprint, IRIS, Palm Print, Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and ... 2022", published by MarketsandMarkets, the market is expected to grow from USD ... a CAGR of 16.79% between 2016 and 2022. ... ...
Breaking Biology News(10 mins):
(Date:12/9/2016)... -- China Cord Blood Corporation (NYSE: CO ) ... provider of cord blood collection, laboratory testing, hematopoietic stem cell ... of its 2016 Annual General Meeting, which was held on ... . At the Annual General Meeting, ... Huazhen LLP as the independent auditors of the Company for ...
(Date:12/9/2016)... 9, 2016 According to a new market ... Custom, Predesigned, Reagent Equipment), Application (Research, PCR, Gene, DNA, NGS, Diagnostic, ... by MarketsandMarkets, the global market is expected to reach USD 2.20 ... CAGR of 10.6% during the forecast period. ... ...
(Date:12/8/2016)... This report analyzes the worldwide markets for Biostimulants in US$ ... Fulvic), Extract Based, and Others. The report also analyzes the ... Row Crops, and Others. The report provides separate comprehensive analytics ... Japan , Europe , ... Rest of World. Annual estimates and forecasts are provided for ...
(Date:12/8/2016)... SAN DIEGO, Dec. 8, 2016  OncoSec Medical ... company developing DNA-based intratumoral cancer immunotherapies, today announced ... "We are delivering on our ... melanoma with ImmunoPulse┬« IL-12. We are pleased with ... melanoma combination trial, and we are focused on ...
Breaking Biology Technology: